Skip to main content

ProQR Therapeutics N.V.

PRQR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001612940

In the last 90 days, ProQR Therapeutics N.V. insiders filed 4 open-market purchases and 0 sales; 70 institutions reported holding it in 13F filings for Q2 2026, worth $113.0M in total; no superinvestor holds it.

Q2 2026 vs. Q1 2026

How the institutions holding ProQR Therapeutics N.V. changed between Q1 2026 and Q2 2026.

All holders in Q2 2026All holders in Q1 2026

13F holders of PRQR: Q1 2026 compared with Q2 2026
MeasureQ1 2026Q2 2026Change
Holders6970+1
Shares35.1M60.7M+25.7M (+73.1%)
Value$56.8M$113.0M+$56.1M (+98.8%)

New holders (12)

Institutions that held ProQR Therapeutics N.V. at the end of Q2 2026 but not at the end of Q1 2026.

Institutions new to PRQR in Q2 2026
InstitutionSharesValue% of portfolio
Woodline Partners LP3,277,143$6.10M0.02%
Heights Capital Management, Inc2,762,430$5.14M1.19%
Sphera Funds Management Ltd.1,757,458$3.27M0.47%
Squadron Capital Management LLC1,511,496$2.81M0.96%
683 Capital Management, LLC1,393,067$2.59M0.24%
Eversept Partners, LP1,022,265$1.90M0.10%
StemPoint Capital LP431,054$801.8K0.14%
Burkehill Global Management, LP176,243$327.8K0.01%
Verdad Advisers, LP19,100$35.5K0.03%
Two Sigma Securities, LLC16,016$29.8K0.00%
Virtu Financial LLC11,626$22.0K0.00%
Wetzel Investment Advisors, Inc.10,500$19.5K0.01%

Sold out (11)

Institutions that held ProQR Therapeutics N.V. at the end of Q1 2026 and filed for Q2 2026 without it.

Institutions that sold out of PRQR in Q2 2026
InstitutionShares, Q1 2026Value, Q1 2026
Sio Capital Management, LLC1,954,715$3.17M
Walleye Capital LLC607,529$984.2K
Northern Trust Corp291,314$471.9K
Marshall Wace, LLP115,945$187.8K
Graham Capital Management, L.P.91,553$148.3K
XTX Topco Ltd77,287$125.2K
Invesco Ltd.44,592$72.2K
Squarepoint Ops LLC31,518$51.1K
Nine Masts Capital Ltd29,518$47.8K
Group One Trading, L.P.18,924$30.7K
Susquehanna International Group, LLP12,206$19.8K